Abstract:<p>To increase the capacity of identifying coronavirus disease 2019 (COVID-19) infection, many Biosafety Level 2 (BSL-2) labs have been established in a short period of time for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) nucleic acid tests all over the world. However, their biosafety has not been evaluated, which could have been the first gateway to SARS-CoV-2 transmission. During 9–11 March 2020, the first comprehensive evaluation of the biosafety in all 89 labs qualified for conducting SARS-CoV-2 tests in Sichuan Province of China was conducted. The degree of compliance with 39 criteria in five categories was evaluated: biosafety requirements for lab activities (14 criteria), sample transfer, acceptance and management (6 criteria), waste management (9 criteria), personnel training and protection (4 criteria), and lab environmental disinfection, emergency plans and accident handling (6 criteria). Our results revealed that, although an overall median compliance rate of 94.6% for 39 criteria, only four of 89 labs met all of them. Criteria in personnel training and protection have been most satisfactorily met, followed by lab environmental disinfection, emergency plans and accident handling. The most severe risk was the lack of automatic doors at the main entrance or in core operation areas, especially among labs in CDC and hospitals. This risk, together with failure for keeping pressure in the core operation areas 25 ± 5 Pa (mainly among labs in the third-party testing agencies), may cause accidental exposure to biological agents from lab activities. Other severe risk included failure for standard labeling of SARS-CoV-2 wastes and lacking regular monitoring of sterilization effects. Our findings would provide experiences and lessons for strengthening lab biosafety in other Chinese provinces, and also serve as an important reference for many other countries where such labs are being or will be quickly built for fighting the COVID-19. The information of lab safety should be considered to be internally linked to the national intelligent syndromic surveillance system (NISSS), for better improving the safety of the labs at the greatest need and facilitating more comprehensive surveillance of risk for disease outbreak.</p>

Reflections on the biosafety of coronavirus research based on synthetic biology methods

Advances in Synthetic Biology and Biosafety Governance

Design and Application of Biosafe Coronavirus Engineering Systems without Virulence

Prevention and Consideration for the Biosafety of Laboratory Testing under Epidemic Condition

Prudently conduct the engineering and synthesis of the SARS-CoV-2 virus

Challenges and recent progress in the governance of biosecurity risks in the era of synthetic biology

Regulation and management of the biosecurity for synthetic biology

Ethical and social insights into synthetic biology: predicting research fronts in the post-COVID-19 era

Biosafety and Immunology: an Interdisciplinary Field for Health Priority

[Principles and Suggestions on Biosafety Protection of Biological Specimen Preservation During Prevalence of COVID-19].

Biosafety and biosecurity in Synthetic Biology: A review

Biosafety and Biosecurity: Treading China's Synbio Tightrope.

Ethical and Social insights into Synthetic Biology: Bibliometric approach and predicting research fronts in POST-COVID-19 era

Bioinformatics research on the SARS coronavirus (SARS_CoV) in China.

Biosafety materials: an emerging new research direction of materials science from the COVID-19 outbreak

Evaluation of simple biosensors for efficient detection of coronavirus: A comprehensive review for the development of real-time monitoring systems

Overlapping and discrete aspects of the pathology and pathogenesis of the emerging human pathogenic coronaviruses SARS‐CoV, MERS‐CoV, and 2019‐nCoV

Biosafety threats of the rapidly established labs for SARS-CoV-2 tests in China

An Interim Review of Lessons from the Novel Coronavirus (Sars-Cov-2) Outbreak in China

In the Shadow of Biological Warfare: Conspiracy Theories on the Origins of COVID-19 and Enhancing Global Governance of Biosafety as a Matter of Urgency

We need a global framework for promoting safe handling of high consequence pathogens